Klotho Therapeutics, Inc.
PrivateLast Round
Series A
Nov 2, 2017
Total Funding Raised
$10M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Klotho Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series A round in November 2017.
Klotho Therapeutics, Inc. is a biotechnology company that develops patent-pending recombinant versions of the human Klotho protein to treat age-related diseases such as kidney disease, cognitive decline, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Klotho Therapeutics, Inc. Comparables
Compare Klotho Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jocasta Neuroscience | 85% | |
| ADvantage Therapeutics Inc. | 83% | |
| Elevian | 79% |
For institutional investors. Book with your work email.
Klotho Therapeutics, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Klotho Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Thynk Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 32% MoM.
- Mar 4, 2026
Monthly visitors increased 51% MoM.
For institutional investors. Book with your work email.
Klotho Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Klotho Therapeutics, Inc.'s valuation, stock price, and market status.
Is Klotho Therapeutics, Inc. a public or private company?
Klotho Therapeutics, Inc. is a private company.
What is the current stock price of Klotho Therapeutics, Inc.?
Klotho Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Klotho Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Klotho Therapeutics, Inc. worth (valuation)?
Valuation information for Klotho Therapeutics, Inc. is not publicly available.
Can I buy Klotho Therapeutics, Inc. stock?
Klotho Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Klotho Therapeutics, Inc.'s last funding round?
Klotho Therapeutics, Inc.'s most recent funding round was Series A on November 2, 2017.
Who are the main investors in Klotho Therapeutics, Inc.?
Key investors in Klotho Therapeutics, Inc. include Thynk Capital.
Will Klotho Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Klotho Therapeutics, Inc..
How can I track Klotho Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Klotho Therapeutics, Inc.'s shares on secondary markets.